#clinicalpracticeguideline risultati di ricerca

📣 New ESMO #Lymphomas Living Guideline v1.0. Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 🔗 ow.ly/FcXW50X7y8q #ESMOGuidelines

myESMO's tweet image. 📣 New ESMO #Lymphomas Living Guideline v1.0. 
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 

🔗 ow.ly/FcXW50X7y8q

#ESMOGuidelines

📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. #DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma

myESMO's tweet image. 📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. 
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma…

📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 🔗 ow.ly/yU4i50WM0Uk #LungCancer #SystemicTherapy #Oncology

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 

🔗 ow.ly/yU4i50WM0Uk

#LungCancer #SystemicTherapy #Oncology…

📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 🔗 ow.ly/kzQF50Wa0lf #LungCancer #mNSCLC #ESMOGuidelines

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 

🔗 ow.ly/kzQF50Wa0lf

#LungCancer #mNSCLC #ESMOGuidelines

📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. #ESMOGuidelines 🔗 ow.ly/q2VV50VWTAU

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. 
#ESMOGuidelines

🔗 ow.ly/q2VV50VWTAU

📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines…

EIC @ceschmalbach discusses “Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis” w/ co-authors Meghan Wilson, MD, and Jason Blakeley Hensler, MD, in the latest OTO Journal Podcast. @AAOHNS #CPG #ClinicalPracticeGuideline sites.libsyn.com/54812/plain-la…


📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. #LungCancer #mNSCLC #ESMOGuidelines 🔗 ow.ly/v7nE50Wbqsf

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. 
#LungCancer #mNSCLC #ESMOGuidelines

🔗 ow.ly/v7nE50Wbqsf

📣 ESMO Living Guideline on Hepatocellular Carcinoma: 👉 New title with the latest recommendations and algorithms in an interactive format. #ClinicalPracticeGuideline @ArndtVogel 🔗 ow.ly/CHpJ50VHbYg

myESMO's tweet image. 📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
#ClinicalPracticeGuideline @ArndtVogel
🔗 ow.ly/CHpJ50VHbYg

📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 🔗 ow.ly/ShMI50VPh7I #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 

🔗 ow.ly/ShMI50VPh7I

#ESMOGuidelines

A detailed #clinicalpracticeguideline on human milk and #breastfeeding during #ketogenicdiet for #epilepsy or #metabolicdiseases stresses that weaning is not required buff.ly/3TmHbZt

mackeithpress's tweet image. A detailed #clinicalpracticeguideline on human milk and #breastfeeding during #ketogenicdiet for #epilepsy or #metabolicdiseases stresses that weaning is not required
buff.ly/3TmHbZt

👉 Access the core content of the Living Guideline in a user-friendly format ready for you to use in your own presentations. 🔗ow.ly/r4UH50VCtR2 #ClinicalPracticeGuideline

myESMO's tweet image. 👉 Access the core content of the Living Guideline in a user-friendly format ready for you to use in your own presentations.

🔗ow.ly/r4UH50VCtR2

#ClinicalPracticeGuideline

.@Otojournals EIC @ceschmalbach discusses “Clinical Practice Guideline: Age-Related Hearing Loss” with lead authors Heather M. Weinreich MD, MPH and Carrie L. Nieman MD, MPH. #CPG #ClinicalPracticeGuideline #AgeRelatedHearingLoss #otolaryngology #ENT sites.libsyn.com/54812/oto-clin…


.@Otojournals EIC @ceschmalbach discusses “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy” with lead author Richard K. Gurgel, MD, & author Stacey L. Ishman, MD, MPH. #ClinicalPracticeGuideline #CPG #immunotherapy #allergy #ENT otojournal.libsyn.com/oto-clinical-p…


Next stop - Mexico City to participate in the XXI obesity course hosted by @incmnszmx incmnsz.mx/Carrusel/2024/… @Obesidades_mx @DrRobertKushner @seanwharton @DrEsquivias Excited to discuss future #clinicalpracticeguideline implementation strategies also!

xramossalas's tweet image. Next stop - Mexico City to participate in the XXI obesity course hosted by @incmnszmx incmnsz.mx/Carrusel/2024/… 
@Obesidades_mx @DrRobertKushner @seanwharton @DrEsquivias 
Excited to discuss future #clinicalpracticeguideline implementation strategies also!

A new Clinical Practice Guideline on Age-Related Hearing Loss was published in @Otojournals on April 30. For the guideline with other supplemental materials, visit entnet.org/arhlcpg. #hearingloss #ARHL #ClinicalPracticeGuideline #CPG #Otolaryngology

AAOHNS's tweet image. A new Clinical Practice Guideline on Age-Related Hearing Loss was published in @Otojournals on April 30. For the guideline with other supplemental materials, visit entnet.org/arhlcpg. #hearingloss #ARHL #ClinicalPracticeGuideline #CPG #Otolaryngology

📣 New ESMO #Lymphomas Living Guideline v1.0. Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 🔗 ow.ly/FcXW50X7y8q #ESMOGuidelines

myESMO's tweet image. 📣 New ESMO #Lymphomas Living Guideline v1.0. 
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 

🔗 ow.ly/FcXW50X7y8q

#ESMOGuidelines

Build patient ed apps with videos/pics/forms on EVAL, no code. Send & manage in clinical panel to save time. Ready to transform education? DM us your idea and we'll help you start on your first app free. #clinicalpracticeguideline #patientsupport #EVALHealth

EvalHealth's tweet image. Build patient ed apps with videos/pics/forms on EVAL, no code. Send & manage in clinical panel to save time. Ready to transform education? DM us your idea and we'll help you start on your first app free. #clinicalpracticeguideline #patientsupport  #EVALHealth

📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 🔗 ow.ly/yU4i50WM0Uk #LungCancer #SystemicTherapy #Oncology

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 

🔗 ow.ly/yU4i50WM0Uk

#LungCancer #SystemicTherapy #Oncology…

📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines…

📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. #DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma

myESMO's tweet image. 📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. 
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma…

EIC @ceschmalbach discusses “Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis” w/ co-authors Meghan Wilson, MD, and Jason Blakeley Hensler, MD, in the latest OTO Journal Podcast. @AAOHNS #CPG #ClinicalPracticeGuideline sites.libsyn.com/54812/plain-la…


EIC @ceschmalbach discusses “Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis” w/authors Jennifer J. Shin, MD, SM, and Dana Crosby, MD, MPH, in this month's OTO Journal Podcast. #ENT #CPG #ClinicalPracticeGuideline #Otolaryngology sites.libsyn.com/54812/clinical…


📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. #LungCancer #mNSCLC #ESMOGuidelines 🔗 ow.ly/v7nE50Wbqsf

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. 
#LungCancer #mNSCLC #ESMOGuidelines

🔗 ow.ly/v7nE50Wbqsf

📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 🔗 ow.ly/kzQF50Wa0lf #LungCancer #mNSCLC #ESMOGuidelines

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 

🔗 ow.ly/kzQF50Wa0lf

#LungCancer #mNSCLC #ESMOGuidelines

📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. #ESMOGuidelines 🔗 ow.ly/q2VV50VWTAU

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. 
#ESMOGuidelines

🔗 ow.ly/q2VV50VWTAU

📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 🔗 ow.ly/ShMI50VPh7I #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 

🔗 ow.ly/ShMI50VPh7I

#ESMOGuidelines

🆕Brand new online! #EHA & #ESMO collaborated to bring you this #ClinicalPracticeGuideline on #PTCL. We warmly invite you to read & share with your contacts 👉 bit.ly/PTCL_GL @myESMO @EHA_Hematology #EHAGuidelines #ESMOGuidelines


📣 ESMO Living Guideline on Hepatocellular Carcinoma: 👉 New title with the latest recommendations and algorithms in an interactive format. #ClinicalPracticeGuideline @ArndtVogel 🔗 ow.ly/CHpJ50VHbYg

myESMO's tweet image. 📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
#ClinicalPracticeGuideline @ArndtVogel
🔗 ow.ly/CHpJ50VHbYg

Nessun risultato per "#clinicalpracticeguideline"

📣 New ESMO #Lymphomas Living Guideline v1.0. Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 🔗 ow.ly/FcXW50X7y8q #ESMOGuidelines

myESMO's tweet image. 📣 New ESMO #Lymphomas Living Guideline v1.0. 
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format. 

🔗 ow.ly/FcXW50X7y8q

#ESMOGuidelines

Build patient ed apps with videos/pics/forms on EVAL, no code. Send & manage in clinical panel to save time. Ready to transform education? DM us your idea and we'll help you start on your first app free. #clinicalpracticeguideline #patientsupport #EVALHealth

EvalHealth's tweet image. Build patient ed apps with videos/pics/forms on EVAL, no code. Send & manage in clinical panel to save time. Ready to transform education? DM us your idea and we'll help you start on your first app free. #clinicalpracticeguideline #patientsupport  #EVALHealth

📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 🔗 ow.ly/kzQF50Wa0lf #LungCancer #mNSCLC #ESMOGuidelines

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved. 

🔗 ow.ly/kzQF50Wa0lf

#LungCancer #mNSCLC #ESMOGuidelines

📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. #LungCancer #mNSCLC #ESMOGuidelines 🔗 ow.ly/v7nE50Wbqsf

myESMO's tweet image. 📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. 
#LungCancer #mNSCLC #ESMOGuidelines

🔗 ow.ly/v7nE50Wbqsf

📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. #DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma

myESMO's tweet image. 📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx. 
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #MantleCellLymphoma…

📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 🔗 ow.ly/yU4i50WM0Uk #LungCancer #SystemicTherapy #Oncology

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes. 

🔗 ow.ly/yU4i50WM0Uk

#LungCancer #SystemicTherapy #Oncology…

A new Clinical Practice Guideline on Age-Related Hearing Loss was published in @Otojournals on April 30. For the guideline with other supplemental materials, visit entnet.org/arhlcpg. #hearingloss #ARHL #ClinicalPracticeGuideline #CPG #Otolaryngology

AAOHNS's tweet image. A new Clinical Practice Guideline on Age-Related Hearing Loss was published in @Otojournals on April 30. For the guideline with other supplemental materials, visit entnet.org/arhlcpg. #hearingloss #ARHL #ClinicalPracticeGuideline #CPG #Otolaryngology

📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 🔗 ow.ly/ShMI50VPh7I #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 

🔗 ow.ly/ShMI50VPh7I

#ESMOGuidelines

📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. #ESMOGuidelines 🔗 ow.ly/q2VV50VWTAU

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. 
#ESMOGuidelines

🔗 ow.ly/q2VV50VWTAU

📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines

myESMO's tweet image. 📣 Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines…

📣 ESMO Living Guideline on Hepatocellular Carcinoma: 👉 New title with the latest recommendations and algorithms in an interactive format. #ClinicalPracticeGuideline @ArndtVogel 🔗 ow.ly/CHpJ50VHbYg

myESMO's tweet image. 📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
#ClinicalPracticeGuideline @ArndtVogel
🔗 ow.ly/CHpJ50VHbYg

👉 Access the core content of the Living Guideline in a user-friendly format ready for you to use in your own presentations. 🔗ow.ly/r4UH50VCtR2 #ClinicalPracticeGuideline

myESMO's tweet image. 👉 Access the core content of the Living Guideline in a user-friendly format ready for you to use in your own presentations.

🔗ow.ly/r4UH50VCtR2

#ClinicalPracticeGuideline

A detailed #clinicalpracticeguideline on human milk and #breastfeeding during #ketogenicdiet for #epilepsy or #metabolicdiseases stresses that weaning is not required buff.ly/3TmHbZt

mackeithpress's tweet image. A detailed #clinicalpracticeguideline on human milk and #breastfeeding during #ketogenicdiet for #epilepsy or #metabolicdiseases stresses that weaning is not required
buff.ly/3TmHbZt

Fortunately @EASLnews provides us with a #clinicalpracticeguideline on #polycystice liver Published last year in @JHepatology sciencedirect.com/science/articl…

joostphdrenth's tweet image. Fortunately @EASLnews provides us with a #clinicalpracticeguideline on #polycystice liver 
Published last year in @JHepatology 

sciencedirect.com/science/articl…

OK let’s see crowd wisdom at work. 46 YO polycystic disease. Huge liver cysts that make her life miserable. Liver and kidney functions ok. Ideas? #surgery #liver #polycystic

amikisz's tweet image. OK let’s see crowd  wisdom at work. 46 YO polycystic disease. Huge liver cysts that make her life miserable. Liver and kidney functions ok. Ideas? #surgery #liver #polycystic
amikisz's tweet image. OK let’s see crowd  wisdom at work. 46 YO polycystic disease. Huge liver cysts that make her life miserable. Liver and kidney functions ok. Ideas? #surgery #liver #polycystic


@Ameriburn developed a new a #ClinicalPracticeGuideline emphasizing acute fluid resuscitation within 48 hours for adults with #burns covering at least 20% TBSA. Discover more highlights from the guideline in our feature here: buff.ly/3LG8rhn #BurnCare #CriticalCare

physicianswkly's tweet image. @Ameriburn developed a new a #ClinicalPracticeGuideline emphasizing acute fluid resuscitation within 48 hours for adults with #burns covering at least 20% TBSA. 

Discover more highlights from the guideline in our feature here: buff.ly/3LG8rhn

#BurnCare #CriticalCare

Next stop - Mexico City to participate in the XXI obesity course hosted by @incmnszmx incmnsz.mx/Carrusel/2024/… @Obesidades_mx @DrRobertKushner @seanwharton @DrEsquivias Excited to discuss future #clinicalpracticeguideline implementation strategies also!

xramossalas's tweet image. Next stop - Mexico City to participate in the XXI obesity course hosted by @incmnszmx incmnsz.mx/Carrusel/2024/… 
@Obesidades_mx @DrRobertKushner @seanwharton @DrEsquivias 
Excited to discuss future #clinicalpracticeguideline implementation strategies also!

If you work with adolescents with #Concussion check out the new #ClinicalPracticeGuideline Supplement 🖐️Special Considerations for initial assessment & multidisciplinary management of adolescents who sustain concussion from intimate partner violence🖐️#IPV pedsconcussion.com/ipv

PedsConcussion's tweet image. If you work with adolescents with #Concussion check out the new #ClinicalPracticeGuideline Supplement

🖐️Special Considerations for initial assessment & multidisciplinary management of adolescents who sustain concussion from intimate partner violence🖐️#IPV pedsconcussion.com/ipv

🚩New #LivingGuideline Clinical Resource🚩 Special considerations for the initial medical assessment, follow-up, & multidisciplinary management of adolescents who sustain head/neck trauma from intimate partner violence. #IPV #Concussion Link: pedsconcussion.com/ipv



Loading...

Something went wrong.


Something went wrong.


United States Trends